Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines [PDF]
, 2018 Somatostatin analogs (SSA) are well-established antisecretory drugs in functionally active neuroendocrine tumors (NET). Two placebo-controlled trials have recently demonstrated significant improvement of progression-free survival under SSA treatment ...
Exner, Samantha +3 more
core +1 more source
A standardised study to compare prostate cancer targeting efficacy of five radiolabelled bombesin analogues [PDF]
, 2010 Purpose: Prostate-specific antigen (PSA)-based screening for prostate cancer (PC) has dramatically increased early diagnosis. Current imaging techniques are not optimal to stage early PC adequately.
A Jemal +44 more
core +4 more sources
RADIONUCLIDE IMAGING AND THERAPY OF NEUROENDOCRINE TUMOURS
Journal of Cancer and Allied Specialties, 2015 The incidence and prevalence of neuroendocrine tumours (NETs) are on the rise. Although NETs are a heterogeneous group of tumours, they have some similar properties, for example, that they can concentrate neuroamines and tend to have a high degree of ...
Shaunak Navalkissoor +1 more
doaj +1 more source
Xiehe Yixue Zazhi, 2022 Peptide receptor radionuclide therapy (PRRT) is one of the advanced therapies for neuroendocrine neoplasms (NENs), which can relieve the symptoms and improve the quality of life of patients with NENs with good tolerance to the treatment.However, since ...
LEI Lei +5 more
doaj +1 more source
Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumors [PDF]
, 2008 Twenty plantain crop fields were sampled to identify Meloidogyne spp. in Tierralta and Valencia municipalities. Ten soil and root samples per field were taken to obtain the nematodes.
Amir Sabet +6 more
core +2 more sources
Year in Review 2018 by the Brazilian Gastrointestinal Tumors Group: Neuroendocrine Tumors
Brazilian Journal of Oncology, 2018 Neuroendocrine tumors (NET) constitute a heterogeneous group of neoplasms with variable prognoses and clinical presentations. Therefore their therapeutic management is challenging, involving a real multidisciplinary approach composed of medical ...
Duilio R. Rocha +2 more
doaj +1 more source
Endocrinology, Diabetes & Metabolism Case Reports, 2022 Acanthosis nigricans (AN) is a common dermatosis associated with hyperinsulinemia and insulin resistance. However, AN has been rarely reported in patients with insulinoma, a state of persistent hyperinsulinemia. We present a case of metastatic insulinoma,
Jenny S W Yun +3 more
doaj +1 more source
Peptides in Receptor-Mediated Radiotherapy: From Design to the Clinical Application in Cancers [PDF]
, 2013 Short peptides can show high affinity for specific receptors overexpressed on tumor cells. Some of these are already used in cancerology as diagnostic tools and others are in clinical trials for therapeutic applications. Therefore, peptides exhibit great
André Pèlegrin +4 more
core +3 more sources
Peptide Receptor Radionuclide Therapy in Thyroid Cancer
Frontiers in Endocrinology, 2022 The treatment options that are currently available for management of metastatic, progressive radioactive iodine (RAI)-refractory differentiated thyroid cancers (DTCs), and medullary thyroid cancers (MTCs) are limited.
Sriram Gubbi +3 more
doaj +1 more source
Peptide Receptor Radionuclide Therapy for Advanced Neuroendocrine Tumors [PDF]
, 2014 No abstract ...
Bodei, Lisa +6 more
core +1 more source